SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-22-003844
Filing Date
2022-02-18
Accepted
2022-02-18 17:06:11
Documents
4
Period of Report
2022-04-14

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A dffn20220218_pre14a.htm PRE 14A 242445
2 dffn20220218_pre14aimg001.gif GRAPHIC 6957
3 dffn20220218_pre14aimg002.jpg GRAPHIC 7463
4 dffn20220218_pre14aimg003.jpg GRAPHIC 7463
  Complete submission text file 0001437749-22-003844.txt   274362
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37942 | Film No.: 22653762
SIC: 2834 Pharmaceutical Preparations